Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Protein microarrays are highly sensitive tools useful for disease diagnosis and studying proteins.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.

Experts say proper treatment and sensitivity are important for women's facial skin issues like acne and unwanted hair.

New treatments for child hair loss due to immune issues are effective but not yet officially approved.

The "color-transition sign" helps tell apart alopecia areata incognita from telogen effluvium by looking at hair color changes.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

A young man with an eating disorder had a life-threatening adrenal crisis due to an autoimmune condition, highlighting the need for better education on managing hormone treatments.

Satoyoshi syndrome is likely an autoimmune disease that mainly affects young women and improves with immune-related treatments.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

The Seoul International Dermatology Symposium was a successful event that highlighted new dermatology treatments and fostered international relations.

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

Scalp pain is a common symptom in people with active hair loss from telogen effluvium.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Adalimumab can cause complete hair loss in rare cases.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Red spots on fingertips can be a sign of a skin condition linked to gluten sensitivity, treatable with a gluten-free diet.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

White piedra, a rare fungal infection, was diagnosed in two women in a northern climate.

People with Alopecia Areata often have lower vitamin D levels, and vitamin D supplements might help treat it.

A 7-year-old dog with a rare autoimmune disease was euthanized due to severe anemia and poor prognosis.

Hair graying is influenced by factors like nerves, fat cells, and immune cells, not just hair follicles.

Certain gene variations may increase the risk and severity of alopecia areata.